Raymond James analyst Gregory Peters maintained an Outperform rating and $90 price target on eHealth following the company's Q3 earnings, which were better than consensus on both EPS and revenue, and reaffirmed FY19 guidance. However, the analyst noted that the stock is down ~8%, which he believes is because of "an increase in Medicare cost per approved member surpassing the constrained LTVs of Medicare policies." Peters feels the reported costs "could be misunderstood by the Street given the increase is primarily related to customer care and enrollment and not variable marketing costs," adding that he thinks the increase is "likely related to the company's new call center."